Potential Pitfalls in Diagnostic and Therapeutic Decision-Making in Pulmonary Embolism-Related Obstructive Shock in Patients with Cancer: A Case Report

Clicks: 4
ID: 321854
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #26 of 251 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 251 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Pulmonary embolism (PE) is a potentially life-threatening condition and represents the third most common cardiovascular syndrome. Patients with cancer are at markedly increased risk of PE and often present with complex metabolic and hemodynamic alterations. Risk stratification in acute PE relies on clinical parameters, biomarkers, and imaging findings to guide therapeutic decisions. However, elevated lactate levels may have alternative etiologies in oncologic patients, potentially leading to overtreatment of patients. Case Summary We report the case of a 60-year-old woman presenting with high-risk bilateral pulmonary embolism complicated by obstructive shock. Initial findings included hypotension, tachycardia, right ventricular dysfunction, elevated troponin, and severe hyperlactatemia. Systemic thrombolysis was administered following multidisciplinary discussion within a Pulmonary Embolism Response Team (PERT). Despite rapid clinical and hemodynamic improvement, serum lactate levels remained persistently elevated without evidence of metabolic acidosis. Imaging revealed a large soft-tissue mass of the right leg, subsequently diagnosed as high-grade B-cell lymphoma. After exclusion or treatment of other possible explanations, the persistent hyperlactatemia was attributed to tumour-related aerobic glycolysis, consistent with the Warburg effect. Given the favourable clinical evolution, further invasive PE therapies were avoided. The patient was transitioned to anticoagulation and oncologic treatment, with a favourable long-term outcome. Discussion This case illustrates how malignancy-associated metabolic alterations, such as the Warburg effect, can interfere with therapy in acute PE. Awareness of alternative causes of hyperlactatemia is essential to avoid unnecessary invasive interventions and to optimize individualized treatment strategies in cancer-associated PE.
Reference Key
openalex_W7170048711 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tom Van den Hoek, Peter Kayaert, Eva De Caluwé, Philippe Timmermans
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag551
URL
https://doi.org/10.1093/ehjcr/ytag551
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.